Back

Discussant review - CABANA.

26 August 2018 (11:40 - 11:45)
Organised by:
Congress Presentation Part of: Clinical Trial Updates Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Christophe Leclercq

Hospital Pontchaillou of Rennes, Rennes (France)

11 More presentations in this session

Presentation thumbnail
COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban
Doctor J. Eikelboom (Hamilton, CA)
Slides Video
Presentation thumbnail
Discussant review - COMPASS.
Professor L. Wallentin (Uppsala, SE)
Slides Video
Presentation thumbnail
CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality
Doctor P. Ridker (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CANTOS.
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation
Professor J. Poole (Seattle, US)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Updates

The Event

Event poster

ESC Congress 2018

26 August 2018 11:40 CET
You may be interested in
thumbnail
Congress Presentation
Strive for sinus rhythm: only sinus rhythm will do
11 May 2026
thumbnail
Congress Presentation
Balancing stroke and bleeding risks: the impact of stopping anticoagulation after aAF ablation - a systematic review and meta-analysis
1 September 2025
thumbnail
Webinar
Key updates from the EHRA/HRS/APHRS/LAHRS 2024 Expert Consensus Statement on Atrial Fibrillation Ablation
10 February 2025
thumbnail
Congress Session
Update on antiarrhythmic therapy
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources